Product image of Navalit (Doxylamine Hydrogen Succinate, Pyridoxine Hydrochloride) supplied by GNH India

Navalit

Active Ingredient:
Doxylamine Hydrogen Succinate, Pyridoxine Hydrochloride
Origin:
EU

Navalit (Doxylamine Hydrogen Succinate, Pyridoxine Hydrochloride)

Doxylamine hydrogen succinate, the active ingredient in Navalit, is a H1 receptor antagonist presented as an oral tablet for oral use. It is combined with pyridoxine hydrochloride to treat nausea and vomiting of pregnancy (morning sickness) in pregnant women.
GNH India supplies Navalit as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Effik Benelux

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Navalit is an antihistamine‑vitamin B6 combination used to manage nausea‑related conditions.

  • Morning sickness (NVP): reduces the frequency and severity of nausea and vomiting in pregnant women.
  • Motion sickness: helps prevent nausea associated with travel by land, sea, or air.
  • Post‑operative nausea and vomiting: may be used as part of a regimen to control nausea after surgery.

How It Works

  • Doxylamine hydrogen succinate blocks H1 histamine receptors in the central nervous system, producing sedative and anti‑emetic effects, while pyridoxine hydrochloride serves as a co‑factor in neurotransmitter synthesis that can modulate nausea pathways. The combined action reduces the central drive to vomit and alleviates nausea symptoms.

Side Effects

Navalit may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Drowsiness: feeling unusually sleepy or fatigued.
  • Dry mouth: reduced salivation leading to a sticky sensation.
  • Constipation: slowed intestinal motility.
  • Blurred vision: temporary difficulty focusing.
  • Headache: mild to moderate cranial pain.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Hallucinations or confusion: altered mental status.
  • Cardiac arrhythmia: irregular heartbeat.
  • Stevens‑Johnson syndrome: severe skin blistering.
  • Seizures: uncontrolled electrical activity in the brain.

Precautions & Warnings

Before using Navalit, consider the following safety measures.

  • Pregnancy risk assessment: use only if the expected benefit outweighs potential risk.
  • Alcohol avoidance: do not consume alcoholic beverages while taking the product.
  • Hepatic impairment: dose may need adjustment in liver disease.
  • Driving and machinery: avoid operating vehicles or heavy equipment if drowsy.
  • Elderly monitoring: start with the lowest effective dose and watch for increased sedation.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Navalit can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Alcohol: potentiates central nervous system depression.
  • Other CNS depressants (e.g., benzodiazepines): may cause excessive sedation.
  • MAO inhibitors: risk of hypertensive crisis.
  • Anticholinergic agents: increase anticholinergic burden.
  • Additional antihistamines: may intensify drowsiness.

Moderate Interactions (Monitor Closely)

  • Selective serotonin reuptake inhibitors (SSRIs): possible serotonin syndrome.
  • Tricyclic antidepressants: may enhance anticholinergic effects.
  • Opioid analgesics: additive sedation.
  • Antacids containing aluminum or magnesium: may affect absorption.
  • CYP450 inhibitors: could raise plasma levels of doxylamine.

Frequently Asked Questions

Navalit is a combination of doxylamine hydrogen succinate and pyridoxine hydrochloride used primarily to relieve nausea and vomiting associated with pregnancy, commonly known as morning sickness. It may also be employed for motion sickness and postoperative nausea under medical guidance.

Doxylamine hydrogen succinate blocks H1 histamine receptors in the brain, producing a sedative effect that dampens the vomiting centre. This antihistaminic action, together with pyridoxine’s role in neurotransmitter synthesis, helps reduce the sensation of nausea.

The appropriate dose of Navalit is determined by a qualified prescriber based on the individual’s clinical condition, severity of symptoms, and any other concurrent medications. Patients should follow the dosing instructions provided by their healthcare professional.

Navalit is intended for use in pregnancy to treat morning sickness, but its safety profile should be evaluated by a healthcare provider. The benefits must outweigh any potential risks. Limited data are available for breastfeeding, so a clinician should assess suitability.

To order Navalit, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Navalit combines an antihistamine with vitamin B6, offering a dual mechanism that can be more effective for some patients than single‑agent antihistamines or vitamin B6 alone. Compared with prescription anti‑emetics such as ondansetron, Navalit is generally considered less potent but may have a more favorable safety profile for mild to moderate nausea.

Navalit should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Navalit is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions given by their prescriber regarding timing relative to meals.

Serious risks, though rare, include severe allergic reactions (anaphylaxis), hallucinations, cardiac arrhythmias, and Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, difficulty breathing, irregular heartbeat, or severe confusion.

Navalit should be avoided by individuals with known hypersensitivity to doxylamine, pyridoxine, or any excipients in the formulation. It is also contraindicated in patients taking monoamine oxidase inhibitors or those with severe hepatic impairment unless specifically directed by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.